Phenylephrine dosage
Pro Research Analysisby 
Searched over 200M research papers for "phenylephrine dosage"
Phenylephrine Dosage for Preventing and Treating Hypotension During Cesarean Delivery
Introduction to Phenylephrine Use in Cesarean Delivery
Phenylephrine is a commonly used vasopressor to manage hypotension during spinal anesthesia for cesarean delivery. Hypotension is a frequent complication in this setting, and effective management is crucial for maternal and fetal well-being. This article synthesizes research findings on the optimal dosing regimens of phenylephrine for both prophylactic and therapeutic purposes.
Prophylactic Phenylephrine Infusion Dosage
Weight-Based Infusion Regimens
A study aimed to determine the effective dose of phenylephrine to prevent hypotension in 50% (ED50) and 90% (ED90) of patients during cesarean delivery under spinal anesthesia. The study found that the ED50 and ED90 were 0.31 µg/kg/min and 0.54 µg/kg/min, respectively, when phenylephrine was administered as a fixed-rate infusion based on body weight .
Fixed-Rate Infusion Regimens
Another study compared different fixed-rate infusion regimens of phenylephrine (25, 50, 75, and 100 µg/min) and found that doses of 25 and 50 µg/min were associated with fewer interventions to maintain maternal systolic blood pressure (SBP) within 20% of baseline compared to higher doses. The study concluded that lower doses provided greater hemodynamic stability .
Therapeutic Phenylephrine Bolus Dosage
Dose-Response in Normotensive and Preeclamptic Parturients
Research comparing phenylephrine bolus doses for treating hypotension in normotensive and preeclamptic parturients found that the ED50 and ED90 for normotensive parturients were 72.1 µg and 107 µg, respectively. For preeclamptic parturients, the ED50 and ED90 were lower at 47.6 µg and 70.7 µg, respectively, indicating a 34% reduction in dose requirements for preeclamptic patients .
Comparative Efficacy of Different Bolus Doses
A study comparing the efficacy of 100 µg, 125 µg, and 150 µg bolus doses of phenylephrine for treating post-spinal hypotension found no significant differences in efficacy among the doses. This suggests that increasing the initial bolus dose above 100 µg does not significantly improve outcomes .
Determination of ED90 for Hypotension Treatment
An up-down sequential allocation study estimated the ED90 of phenylephrine for treating spinal anesthesia-induced hypotension to be approximately 150 µg. This dose was effective in 90% of cases without causing hypertension .
Safety and Cardiovascular Tolerability
Cardiovascular Effects of Oral Phenylephrine
A study on the pharmacokinetics and safety of oral phenylephrine (10, 20, and 30 mg) found that the drug was rapidly absorbed and well-tolerated, with no significant cardiovascular adverse effects compared to placebo. This suggests that phenylephrine is safe for use in controlled doses .
Impact on Maternal and Fetal Outcomes
Research has shown that while higher doses of phenylephrine (100 µg/min) can effectively control SBP, they may also cause significant reductions in maternal heart rate and cardiac output. However, no adverse effects on fetal outcomes were observed, indicating that phenylephrine is generally safe for both mother and fetus when used appropriately .
Conclusion
Phenylephrine is an effective vasopressor for managing hypotension during cesarean delivery under spinal anesthesia. Prophylactic infusion doses of 0.31 µg/kg/min (ED50) and 0.54 µg/kg/min (ED90) are effective, while therapeutic bolus doses around 100-150 µg are recommended for treating hypotension. Lower fixed-rate infusions (25-50 µg/min) provide better hemodynamic stability. Phenylephrine is generally safe, with minimal cardiovascular adverse effects when used within the recommended dosing ranges. Further research may focus on optimizing dosing regimens to enhance maternal and fetal outcomes.
Sources and full results
Most relevant research papers on this topic